F Alghisi
Overview
Explore the profile of F Alghisi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Federici A, De Marchis M, Alghisi F, Fiocchi A, Bella S
Clin Ter
. 2022 Sep;
173(5):440-442.
PMID: 36155730
Background: Cystic fibrosis (CF) is the most common autosomal recessive genetic pathology of the Caucasian race and it affects nearly 100,000 people worldwide (many have not been diagnosed) and, in...
2.
De Biase R, Cristiani L, Paglia C, Alghisi F, Giordani B, Lucidi V, et al.
Clin Ter
. 2020 Sep;
171(5):e381-e384.
PMID: 32901778
Objectives: Evaluation of the effectiveness of home care through a telemonitoring system in reducing the incidence of new colonization by Pseudomonas Aeruginosa in a population of patients with Cystic Fibrosis...
3.
Bella S, Murgia F, Cotognini C, Alghisi F, Montemitro E
Clin Ter
. 2013 Sep;
164(4):e313-7.
PMID: 24045530
Objectives: In present study we tested the possible presence of a saving for Italian National Health Service (INHS) when using telemonitoring in the follow-up at home of patients with Cystic...
4.
Monti L, Manco M, Lo Zupone C, Latini A, DAndrea M, Alghisi F, et al.
Radiol Med
. 2012 Sep;
117(8):1408-18.
PMID: 22986694
Purpose: Cystic-fibrosis-associated liver disease (CFLD) may lead to portal hypertension (PHT) and cirrhosis. Clinical signs and biochemistry of liver involvement are not discriminating. The aim of the study was to...
5.
Murgia F, Cilli M, Renzetti E, Popa N, Romano T, Alghisi F, et al.
Clin Ter
. 2011 May;
162(2):e43-9.
PMID: 21533308
Objectives: We attempted to quantify the cost-effectiveness ratio in telemonitoring lung function of patients affected by Cystic Fibrosis (CF). Materials And Methods: We examined the costs of Telehomecare (THC) in...
6.
Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene
Paladini F, Cocco E, Cascino I, Belfiore F, Badiali D, Piretta L, et al.
Neurogastroenterol Motil
. 2009 Mar;
21(6):597-602.
PMID: 19309439
Idiopathic achalasia is a rare disorder of the oesophagus of unknown aetio-pathogenesis characterized by a myenteric inflammation, aperistalsis and insufficient lower oesophageal sphincter relaxation. Vasoactive intestinal peptide (VIP), present in...
7.
Alghisi F, Angioni A, Tomaiuolo A, DApice M, Bella S, Novelli G, et al.
J Cyst Fibros
. 2008 Jan;
7(4):292-294.
PMID: 18180206
Non-classic Cystic Fibrosis (CF) still represents a difficult entity to diagnose. We present a case of two sisters affected by mild pulmonary symptoms started at puberty, carriers of the F508del...
8.
Pallotta N, Calabrese E, Alghisi F, Corazziari E
Diabetes Nutr Metab
. 2004 May;
17(1):37-42.
PMID: 15163124
No abstract available.
9.
Calabrese E, Alghisi F, Corazziari E, Pallotta N
Diabetes Nutr Metab
. 2004 May;
17(1):29-33.
PMID: 15163122
No abstract available.
10.
Di Cocco B, Calabretta F, Alghisi F, Salesi N, Bossone G
Minerva Ginecol
. 2003 Oct;
55(4):327-32.
PMID: 14581857
Many circulating markers are already in clinical practice and in experimental use for the diagnosis, therapeutic monitoring, and in the follow-up of ovarian cancer. The cancer antigen-125 (CA-125) has shown...